Pharmacy Quality Solutions, Inc.

Belkins
Pharmacy Quality Solutions is the leading provider of medication use quality assessment services. We deliver the quality insights and guidance necessary to support our customers'​ efforts to optimize the quality of medication use for the populations they serve.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

VACCINE HEROES? COVID-19 PITFALLS, PRICING PUT PHARMA ON THE SPOT

Fiercepharma | June 16, 2020

news image

Pharma is looking to reset its image with COVID-19 vaccines and treatments, but landmines loom—with pricing likely the biggest. The halo from pharma’s rapid response in research and discovery—and the hope that a vaccine or effective treatments will allow the world to return to some sort of normal—has propelled the industry’s reputation at an all-time high. Forty percent of Americans say their opinion of the pharma industry has turned positive during the COVID-19 pan...

Read More

CORONAVIRUS: THE LATEST PROBLEM BIG PHARMA WON’T SOLVE

Barron's | February 07, 2020

news image

Time for new pharmaceutical-innovation models. The pharmaceutical industry is one of the most profitable on earth, expected to be worth $1.4 trillion by the end of 2020. Last year, the four drug companies that dominated the vaccine market made $30 billion selling vaccines. The pharmaceutical industry benefits from considerable incentives, including in the form of patents and other market monopolies to sustain vaccine and treatment prices well above production cost. Society pays this price—...

Read More

PHARMACY MARKET

THERMO FISHER SCIENTIFIC AND ASTRAZENECA TO CO-DEVELOP NGS-BASED COMPANION DIAGNOSTICS

Thermo Fisher Scientific | September 03, 2021

news image

Thermo Fisher Scientific's clinical sequencing business and AstraZeneca today announced they will co-develop next-generation sequencing (NGS)-based companion diagnostics (CDx) to support AstraZeneca's expanding portfolio of targeted therapies. The companies will collaborate under a multiyear, global agreement. "As the pipeline of targeted therapies expands, the availability of diagnostic tools that can interrogate multiple biomarkers simultaneously will ensure patient...

Read More

BUSINESS INSIGHTS

CATO SMS ACQUIRES NUVENTRA IN ORDER TO EXPAND ITS DRUG DEVELOPMENT OFFERING INTO CLINICAL PHARMACOLOGY

Nuventra, CATO SMS | May 27, 2021

news image

CATO SMS, a global provider of regulatory and clinical research services, announced today the acquisition of Nuventra, Inc., to expand its offering into the critical area of clinical pharmacology. Nuventra, headquartered in Durham, North Carolina, is a leading company in clinical pharmacology science and services. The acquisition expands CATO SMS's portfolio of specialized solutions that help biopharmaceutical companies with drug development by providing a key set of skills targeted at signi...

Read More

Fiercepharma | June 16, 2020

news image

VACCINE HEROES? COVID-19 PITFALLS, PRICING PUT PHARMA ON THE SPOT

Pharma is looking to reset its image with COVID-19 vaccines and treatments, but landmines loom—with pricing likely the biggest. The halo from pharma’s rapid response in research and discovery—and the hope that a vaccine or effective treatments will allow the world to return to some sort of normal—has propelled the industry’s reputation at an all-time high. Forty percent of Americans say their opinion of the pharma industry has turned positive during the COVID-19 pan...

Read More

Barron's | February 07, 2020

news image

CORONAVIRUS: THE LATEST PROBLEM BIG PHARMA WON’T SOLVE

Time for new pharmaceutical-innovation models. The pharmaceutical industry is one of the most profitable on earth, expected to be worth $1.4 trillion by the end of 2020. Last year, the four drug companies that dominated the vaccine market made $30 billion selling vaccines. The pharmaceutical industry benefits from considerable incentives, including in the form of patents and other market monopolies to sustain vaccine and treatment prices well above production cost. Society pays this price—...

Read More

PHARMACY MARKET

Thermo Fisher Scientific | September 03, 2021

news image

THERMO FISHER SCIENTIFIC AND ASTRAZENECA TO CO-DEVELOP NGS-BASED COMPANION DIAGNOSTICS

Thermo Fisher Scientific's clinical sequencing business and AstraZeneca today announced they will co-develop next-generation sequencing (NGS)-based companion diagnostics (CDx) to support AstraZeneca's expanding portfolio of targeted therapies. The companies will collaborate under a multiyear, global agreement. "As the pipeline of targeted therapies expands, the availability of diagnostic tools that can interrogate multiple biomarkers simultaneously will ensure patient...

Read More

BUSINESS INSIGHTS

Nuventra, CATO SMS | May 27, 2021

news image

CATO SMS ACQUIRES NUVENTRA IN ORDER TO EXPAND ITS DRUG DEVELOPMENT OFFERING INTO CLINICAL PHARMACOLOGY

CATO SMS, a global provider of regulatory and clinical research services, announced today the acquisition of Nuventra, Inc., to expand its offering into the critical area of clinical pharmacology. Nuventra, headquartered in Durham, North Carolina, is a leading company in clinical pharmacology science and services. The acquisition expands CATO SMS's portfolio of specialized solutions that help biopharmaceutical companies with drug development by providing a key set of skills targeted at signi...

Read More